Wuya College of Innovation Shenyang Pharmaceutical University Shenyang 110016 ChinaDepartment of Laboratory Medicine The First Affiliated Hospital China Medical University Shenyang 110001 China;
Ministry of Education Heilongjiang University Harbin 150500 ChinaSino-Russian Joint Graduate School Heilongjiang University Harbin 150080 China;
Wuya College of Innovation Shenyang Pharmaceutical University Shenyang 110016 China;
Wuya College of Innovation Shenyang Pharmaceutical University Shenyang 110016 China;
Department of Laboratory Medicine The First Affiliated Hospital China Medical University Shenyang 110001 China;
Wuya College of Innovation Shenyang Pharmaceutical University Shenyang 110016 China;
Wuya College of Innovation Shenyang Pharmaceutical University Shenyang 110016 China;
Wuya College of Innovation Shenyang Pharmaceutical University Shenyang 110016 China;
Wuya College of Innovation Shenyang Pharmaceutical University Shenyang 110016 China;
Wuya College of Innovation Shenyang Pharmaceutical University Shenyang 110016 China;
Wuya College of Innovation Shenyang Pharmaceutical University Shenyang 110016 China;
Department of Laboratory Medicine The First Affiliated Hospital China Medical University Shenyang 110001 China;
School of Life Science and Biopharmaceutics Shenyang Pharmaceutical University Shenyang 110016 China;
School of Life Science and Biopharmaceutics Shenyang Pharmaceutical University Shenyang 110016 China;
Ministry of Education Heilongjiang University Harbin 150500 ChinaSchool of Life Sciences Heilongjiang University Harbin 150080 China;
Wuya College of Innovation Shenyang Pharmaceutical University Shenyang 110016 China;
Prodrug nanoplatform; Disulfide bond; Pyropheophorbide a; Redox-heterogeneity; Accurate therapy;